Vytala™ Announces New Clinical Data and IRB Approval for Seracal™
Two abstracts to be presented at leading medical conferences highlight broadening clinical use of Seracal™ and a new IRB approval DOWNINGTON, PA, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Vytala, a healthcare-focused food technology company, today announced important milestones for Seracal™, its novel medical food designed to address fat malabsorption. Throughout the year Seracal continues to see rapid adoption, with monthly sales growth exceeding 30%, supported by strong clinician demand, …